Perry Hm
Impact in
-
- Blood Pressure and Hypertension Studies
- Cardiovascular Health and Disease Prevention
-
- Heavy Metal Exposure and Toxicity
Papers in
-
- Heavy Metal Exposure and Toxicity 4
- Mercury impact and mitigation studies 1
-
- Various Chemistry Research Topics 2
- Chemical Reactions and Mechanisms 1
- Co-authors
- Sharon E. Carmody (2 shared papers)E M Tan (1 shared paper)Margaret W. Erlanger (4 shared papers)Smith Wm (2 shared papers)Grimm Rh (1 shared paper)M. Donald Blaufox (1 shared paper)Black Hr (1 shared paper)ELEANOR B. SCHRON (1 shared paper)
- Journals
- American Journal of Physiology-Legacy Content (2 papers)JAMA (1 paper)PubMed (31 papers)
- Partner nations
- United States
In The Last Decade
Perry Hm
32 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 118
- Cardiology and Cardiovascular Medicine 435
- Health, Toxicology and Mutagenesis 264
- Nutrition and Dietetics 250
- Pharmacology 90
- Endocrinology, Diabetes and Metabolism 126
Countries citing papers authored by Perry Hm
This map shows the geographic impact of Perry Hm's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Perry Hm with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Perry Hm more than expected).
Fields of papers citing papers by Perry Hm
This network shows the impact of papers produced by Perry Hm. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Perry Hm. The network helps show where Perry Hm may publish in the future.
Co-authors
The 25 scholars most cited alongside Perry Hm, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 34 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2000 | 255 | |
| 2 | Relationship of acetyl transferase activity to antinuclear antibodies and toxic symptoms in hypertensive patients treated with hydralazine. | 1970 | 236 |
| 3 | Prevention of heart failure by antihypertensive drug treatment in older persons with isolated systolic hypertension. SHEP Cooperative Research Group. | 1997 | 149 |
| 4 | Metal-induced hypertension following chronic feeding of low doses of cadmium and mercury. | 1974 | 94 |
| 5 | Impact of the treatment of isolated systolic hypertension on behavioral variables. Results from the systolic hypertension in the elderly program. | 1994 | 70 |
| 6 | Variability in the metal content of human organs. | 1962 | 60 |
| 7 | Elevated circulating renin activity in rats following doses of cadmium known to induce hypertension. | 1973 | 52 |
| 8 | Antihypertensive effects of metal binding agents. | 1955 | 41 |
| 9 | 1970 | 40 | |
| 10 | 1971 | 39 | |
| 11 | Treatment of mild hypertension. Preliminary results of a two-year feasibility trial. | 1977 | 36 |
| 12 | Studies on the control of hypertension by hyphex. III. Pharmacological and chemical observations on 1-hydrazinophthalazine. | 1954 | 33 |
| 13 | Cadmium and lead effects on myocardial function and metabolism. | 1980 | 30 |
| 14 | Immunologic findings in patients receiving methyldopa: a prospective study. | 1971 | 30 |
| 15 | Mechanisms of the acute hypertensive effect of intra-arterial cadmium and mercury in anesthetized rats. | 1967 | 25 |
| 16 | A method of quantitating 1-hydrazinophthalazine in body fluids. | 1953 | 24 |
| 17 | Renin and erythropoietin in normotensive and in hypertensive patients. | 1968 | 23 |
| 18 | Systolic Hypertension in the Elderly Program, Pilot Study (SHEP-PS): morbidity and mortality experience. | 1986 | 19 |
| 19 | Distribution of hydralazine-1-C-14 after injection into normal mice. | 1962 | 19 |
| 20 | Clonidine (Catapres): a new antihypertensive agent. | 1970 | 17 |
About Perry Hm
Perry Hm is a scholar working on Health, Toxicology and Mutagenesis, Physical and Theoretical Chemistry, Pharmaceutical Science, Hematology and Endocrinology, Diabetes and Metabolism, having authored 34 papers that have together received 1.4k indexed citations. Recurring topics across this work include Heavy Metal Exposure and Toxicity (4 papers), Chemical Reactions and Isotopes (2 papers), Various Chemistry Research Topics (2 papers), Hormonal Regulation and Hypertension (2 papers), Blood Pressure and Hypertension Studies (2 papers), Chemical Reactions and Mechanisms (1 paper), Diet and metabolism studies (1 paper) and Mercury impact and mitigation studies (1 paper). The work is most often cited by research in Cardiology and Cardiovascular Medicine (435 citations), Health, Toxicology and Mutagenesis (264 citations), Nutrition and Dietetics (250 citations), Pharmacology (90 citations) and Endocrinology, Diabetes and Metabolism (126 citations). Perry Hm has collaborated with scholars based in United States. Frequent co-authors include Sharon E. Carmody, E M Tan, Margaret W. Erlanger, Smith Wm, Grimm Rh, M. Donald Blaufox, Black Hr, ELEANOR B. SCHRON, Robert H. McDonald and Ben Davis. Their work appears in journals such as American Journal of Physiology-Legacy Content, JAMA and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.